Prostate-specific antigen: Update 2006

被引：25
作者：
Freedland, SJ
Partin, AW
机构：
[1] Duke Univ, Med Ctr, Sch Med, Dept Surg,Div Urol, Durham, NC 27710 USA
[2] Johns Hopkins Sch Med, James Buchanan Brady Urol Inst, Dept Urol, Baltimore, MD USA
来源：
UROLOGY | 2006年 / 67卷 / 03期
关键词：
D O I：
10.1016/j.urology.2005.12.026
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：458 / 460
页数：3
相关论文
共 12 条
[1]   Preoperative PSA and progression-free survival after radical prostatectomy for stage T1c disease [J].
Antenor, JAV ;
Roehl, KA ;
Eggener, SE ;
Kundu, SD ;
Han, M ;
Catalona, WJ .
UROLOGY, 2005, 66 (01) :156-160
[2]   LONGITUDINAL EVALUATION OF PROSTATE-SPECIFIC ANTIGEN LEVELS IN MEN WITH AND WITHOUT PROSTATE DISEASE [J].
CARTER, HB ;
PEARSON, JD ;
METTER, J ;
BRANT, LJ ;
CHAN, DW ;
ANDRES, R ;
FOZARD, JL ;
WALSH, PC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (16) :2215-2220
[3]   Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy [J].
D'Amico, AV ;
Renshaw, AA ;
Sussman, B ;
Chen, MH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (04) :440-447
[4]   Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy [J].
D'Amico, AV ;
Chen, MH ;
Roehl, KA ;
Catalona, WJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (02) :125-135
[5]   The prostatic specific antigen era is alive and well: Prostatic specific antigen and biochemical progression following radical prostatectomy [J].
Freedland, SJ ;
Mangold, LA ;
Walsh, PC ;
Partin, AW .
JOURNAL OF UROLOGY, 2005, 174 (04) :1276-1281
[6]   Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy [J].
Freedland, SJ ;
Humphreys, EB ;
Mangold, LA ;
Eisenberger, M ;
Dorey, FJ ;
Walsh, PC ;
Partin, AW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (04) :433-439
[7]  
KURIYAMA M, 1980, Cancer Research, V40, P4658
[8]   Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen [J].
Punglia, RS ;
D'Amico, AV ;
Catalona, WJ ;
Roehl, KA ;
Kuntz, KM .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (04) :335-342
[9]   The prostate specific antigen era in the United States is over for prostate cancer: What happened in the last 20 years? [J].
Stamey, TA ;
Caldwell, M ;
McNeal, JE ;
Nolley, R ;
Hemenez, M ;
Downs, J .
JOURNAL OF UROLOGY, 2004, 172 (04) :1297-1301
[10]   Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter [J].
Thompson, IM ;
Pauler, DK ;
Goodman, PJ ;
Tangen, CM ;
Lucia, MS ;
Parnes, HL ;
Minasian, LM ;
Ford, LG ;
Lippman, SM ;
Crawford, ED ;
Crowley, JJ ;
Coltman, CA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (22) :2239-2246
12